Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 129.63%372M | 65.97%317M | -7.89%1.1B | -2.43%362M | -1.55%382M | -4.14%162M | -27.38%191M | 16.20%1.19B | -11.88%371M | 189.55%388M |
| Net income from continuing operations | 46.83%185M | 16.20%165M | -166.42%-176M | -19.57%74M | -317.74%-518M | -19.23%126M | 0.71%142M | -57.40%265M | -42.14%92M | -169.27%-124M |
| Operating gains losses | 20.00%-4M | -400.00%-3M | -217.86%-33M | ---28M | -103.33%-1M | -600.00%-5M | 133.33%1M | 203.70%28M | --0 | 150.00%30M |
| Depreciation and amortization | 1.96%156M | 3.38%153M | 5.71%629M | 6.37%167M | 9.52%161M | 5.52%153M | 1.37%148M | 2.23%595M | 9.03%157M | 0.00%147M |
| Asset impairment expenditure | ---- | ---- | 158.11%684M | --0 | 158.11%684M | ---- | ---- | --265M | --0 | --265M |
| Remuneration paid in stock | 137.50%19M | 33.33%20M | -48.98%25M | 120.00%1M | -94.44%1M | -52.94%8M | -21.05%15M | -26.87%49M | -122.73%-5M | 20.00%18M |
| Deferred tax | 60.47%69M | 26.67%57M | 12.95%157M | -3.70%26M | 38.71%43M | -2.27%43M | 21.62%45M | -9.15%139M | 22.73%27M | -29.55%31M |
| Other non cashItems | -40.30%40M | 6.25%51M | 20.41%295M | 29.13%133M | -7.84%47M | 26.42%67M | 26.32%48M | 25.00%245M | 53.73%103M | -32.00%51M |
| Change In working capital | 95.17%-7M | 86.84%-15M | -7,850.00%-159M | -27.54%50M | -20.63%50M | 11.59%-145M | -480.00%-114M | 99.46%-2M | 11.29%69M | 121.88%63M |
| -Change in receivables | -366.67%-112M | 378.95%106M | -200.00%-165M | -41.82%-78M | 83.97%-25M | 81.54%-24M | -113.29%-38M | 73.17%-55M | -466.67%-55M | -147.62%-156M |
| -Change in inventory | 74.63%-17M | -86.96%3M | 112.31%24M | 612.50%82M | -131.82%-14M | 50.00%-67M | 125.84%23M | 50.76%-195M | -328.57%-16M | 115.88%44M |
| -Change in prepaid assets | 533.33%19M | -42.86%-10M | 33.33%-2M | 133.33%28M | -188.89%-26M | -57.14%3M | 46.15%-7M | 70.00%-3M | 340.00%12M | -200.00%-9M |
| -Change in payables and accrued expense | 280.70%103M | -23.91%-114M | -106.37%-16M | -85.00%18M | -39.47%115M | -161.29%-57M | 41.03%-92M | 3.29%251M | 122.22%120M | 287.76%190M |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -200.00%-6M |
| Interest paid (cash flow from operating activities) | 7.41%-25M | 1.67%-59M | -8.47%-192M | -29.63%-35M | -9.38%-70M | 15.63%-27M | -11.11%-60M | -23.78%-177M | 6.90%-27M | -36.17%-64M |
| Tax refund paid | -5.17%-61M | -52.94%-52M | 38.43%-133M | 42.22%-26M | 48.28%-15M | -13.73%-58M | 62.64%-34M | -272.41%-216M | -114.29%-45M | -866.67%-29M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 129.63%372M | 65.97%317M | -7.89%1.1B | -2.43%362M | -1.55%382M | -4.14%162M | -27.38%191M | 16.20%1.19B | -11.88%371M | 189.55%388M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 10.00%-81M | -2,250.00%-47M | 56.29%-285M | 44.33%-113M | 42.86%-80M | 39.60%-90M | 98.75%-2M | -3.16%-652M | 34.73%-203M | 0.00%-140M |
| Net PPE purchase and sale | 10.11%-80M | -4,500.00%-46M | 56.49%-278M | 45.23%-109M | 42.75%-79M | 39.04%-89M | 99.36%-1M | -5.10%-639M | 34.54%-199M | -3.76%-138M |
| Net intangibles purchas and sale | 0.00%-1M | 0.00%-1M | 46.15%-7M | 0.00%-4M | 50.00%-1M | 66.67%-1M | 75.00%-1M | 45.83%-13M | 42.86%-4M | 71.43%-2M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 10.00%-81M | -2,250.00%-47M | 56.29%-285M | 44.33%-113M | 42.86%-80M | 39.60%-90M | 98.75%-2M | -3.16%-652M | 34.73%-203M | 0.00%-140M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2,440.00%-254M | 1.50%-262M | -200.29%-1.03B | -157.60%-322M | -193.88%-432M | 79.59%-10M | -1,109.09%-266M | 7.05%-343M | -177.78%-125M | -63.33%-147M |
| Net issuance payments of debt | -236.23%-94M | 67.91%-60M | -415.60%-562M | -143.14%-124M | -259.55%-320M | 885.71%69M | -879.17%-187M | 49.30%-109M | -131.82%-51M | -97.78%-89M |
| Net common stock issuance | ---94M | ---123M | -1,445.45%-148M | -2,460.00%-118M | ---31M | --0 | --0 | -75.56%11M | -80.77%5M | --0 |
| Cash dividends paid | -2.50%-82M | 0.00%-79M | -30.61%-320M | -1.27%-80M | -39.66%-81M | -37.93%-80M | -58.00%-79M | -23.12%-245M | -61.22%-79M | -16.00%-58M |
| Proceeds from stock option exercised by employees | 1,500.00%16M | ---- | ---- | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2,440.00%-254M | 1.50%-262M | -200.29%-1.03B | -157.60%-322M | -193.88%-432M | 79.59%-10M | -1,109.09%-266M | 7.05%-343M | -177.78%-125M | -63.33%-147M |
| Net cash flow | ||||||||||
| Beginning cash position | -34.86%256M | -44.85%257M | 77.19%466M | -23.08%330M | 34.22%455M | 4.52%393M | 77.19%466M | 59.39%263M | 131.89%429M | 25.56%339M |
| Current changes in cash | -40.32%37M | 110.39%8M | -211.22%-218M | -269.77%-73M | -228.71%-130M | 313.79%62M | -195.06%-77M | 716.67%196M | -33.85%43M | 205.21%101M |
| Effect of exchange rate changes | --3M | -325.00%-9M | 28.57%9M | --0 | 145.45%5M | --0 | -87.50%4M | -90.54%7M | -146.15%-6M | -200.00%-11M |
| End cash Position | -34.95%296M | -34.86%256M | -44.85%257M | -44.85%257M | -23.08%330M | 34.22%455M | 4.52%393M | 77.19%466M | 77.19%466M | 131.89%429M |
| Free cash from | 305.63%288M | 170.97%252M | 26.82%681M | 29.17%217M | 21.95%300M | 255.00%71M | -9.71%93M | 39.84%537M | 54.13%168M | 3,175.00%246M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.